Cannabinoids are the naturally occurring active chemical compounds found in marijuana that work together to produce varying psychoactive and non-psychoactive effects. Understanding the cannabinoid composition of different products and strains is vital to ensuring that patients receive the desired medicinal effects to treat their symptoms. Anresco Laboratories has the capability to perform a cannabinoid profile via 3 different methodologies. GC-FID (Gas Chromatography with Flame Ionization Detector) can be used to accurately derive the potency of 6 cannabinoids: tetrahydrocannabinol (∆9-THC+∆8-THC), cannabidiol (CBD), cannabigerol (CBG), cannabinol (CBN), and cannabichromene (CBC). Anresco can additionally quantify Δ9-tetrahydrocannabinolic acid (THCA) and cannabidiolic acid (CBDA) via LC-UV (Liquid Chromatography-UV, the AHP recommended method) or LCMSMS (Liquid Chromatography/Tandem Mass Spectrometry). Click here to learn more about the pros and cons of each method.
All cannabinoid analyses are performed according to the most current version of the cannabis inflorescence monograph published by the American Herbal Pharmacopoeia.